Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome-Reference-Cited by-同舟云学术

Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome

Published:2016-09-02 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Otani Koji,Watanabe Toshio,Shimada Sunao,Takeda Shogo,Itani Shigehiro,Higashimori Akira,Nadatani Yuji,Nagami Yasuaki,Tanaka Fumio,Kamata Noriko,Yamagami Hirokazu,Tanigawa Tetsuya,Shiba Masatsugu,Tominaga Kazunari,Fujiwara Yasuhiro,Arakawa Tetsuo

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep32587.pdf

Reference46 articles.

1. Graham, D. Y., Opekun, A. R., Willingham, F. F. & Qureshi, W. A. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 3, 55–59, doi: 10.1016/S1542-3565(04)00603-2 (2005).

2. Sugimori, S. et al. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs. Digestion 78, 208–213, doi: 10.1159/000190403 (2008).

3. Watanabe, T. et al. Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage. Dig Liver Dis 45, 390–395, doi: 10.1016/j.dld.2012.12.005 (2013).

4. Watanabe, T. et al. Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients. Gut 63, 409–414, doi: 10.1136/gutjnl-2013-304713 (2014).

5. Goldstein, J. L. et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 3, 133–141, doi: 10.1016/S1542-3565(04)00619-6 (2005).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRP3 Inflammasomes: Dual Function in Infectious Diseases;The Journal of Immunology;2024-08-15

2. Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes;Diabetology & Metabolic Syndrome;2024-06-25

3. The effect of colchicine on cancer risk in patients with immune-mediated inflammatory diseases: a time-dependent study based on the Taiwan’s National Health Insurance Research Database;European Journal of Medical Research;2024-04-22

4. Colchicine alleviates interstitial lung disease in mice with experimental autoimmune myositis by inhibiting the formation of neutrophil extracellular traps;2024-03-21

5. Antifibrotic effects of colchicine on 3T3 cell line ischemia to mitigate detrimental remodeling;Journal of Pharmacy & Pharmacognosy Research;2024-03-01